A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer
Andre Mihaljevic, Peter Büchler, Jan Harder, Ralf Hofheinz, Michael Gregor, Stephan Kanzler, Wolff Schmiegel, Volker Heinemann, Esther Endlicher, Günter Klöppel, Thomas Seufferlein, Michael GeisslerVolume:
9
Language:
english
DOI:
10.1186/1471-2482-9-1
Date:
December, 2009
File:
PDF, 528 KB
english, 2009